GLP-2(T).

GLP-2(T) is a tirzepatide-class dual GIP and GLP-1 receptor co-agonist research peptide. With the molecular formula C₂₂₅H₃₄₈N₄₈O₆₈ and a molecular weight of 4813.5 g/mol (CAS: 2023788-19-2), it is a 3...

$82.00

Select Protocol

Lab Verified

Clinical Grade

PMID Cited

Mechanism of Action.

Published preclinical research has characterized the following molecular pathways and receptor interactions for GLP-2(T).

Gs-protein coupled cAMP signaling

GIP Receptor (GIPR)

Tirzepatide-class peptides engage the GIP receptor with high affinity, activating adenylyl cyclase and elevating intracellular cAMP in beta-cell and adipocyte culture models.

Concurrent incretin receptor co-agonism

GLP-1 Receptor (GLP-1R)

The same molecule simultaneously engages the GLP-1 receptor, letting researchers study combined GIPR/GLP-1R cAMP signaling that single-agonist tools cannot replicate.

Evidence Based

Clinical Literature

View All Studies

Preclinical

Research review on GLP-2(T) molecular characterization.

Preclinical studies have characterized the molecular properties and receptor binding profiles of GLP-2(T) in standardized assay systems.

Preclinical

GLP-2(T) structure-activity relationship analysis.

Structure-activity relationship studies have examined the functional domains and binding characteristics of GLP-2(T) in cell-free and cell-based systems.

RESEARCH USE ONLY: This compound is intended exclusively for in vitro laboratory research. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. Not evaluated by the FDA. Must be 21+ to purchase.

Continue Exploring